Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: Mexico has been experiencing some of the most rapid shifts ever recorded in dietary and physical activity patterns leading to obesity. Diabetes mellitus has played a crucial role causing nearly 14% of all deaths. We wanted to make a comprehensive study of the role of diabetes in terms of burden of disease, prevalence, cost of diabetes, cost of complications and health policy. Method: We review the quantitative data that provides evidence of the extent to which the Mexican health economy is affected by the disease and its complications. We then discuss the current situation of diabetes in Mexico with experts in the field. Results: There was a significant increase in the prevalence of diabetes from 1994 to 2006 with rising direct costs (2006: outpatient USD$ 717,764,787, inpatient USD$ 223,581,099) and indirect costs (2005: USD$ 177,220,390), and rising costs of complications (2010: Retinopathy USD$ 10,323,421; Cardiovascular disease USD$ 12,843,134; Nephropathy USD$ 81,814,501; Neuropathy USD$ 2,760,271; Peripheral vascular disease USD$ 2,042,601). The health policy focused on screening and the creation of self-support groups across the country. Conclusions: The increasing diabetes mortality and lack of control among diagnosed patients make quality of treatment a major concern in Mexico. The growing prevalence of childhood and adult obesity and the metabolic syndrome suggest that the situation could be even worse in the coming years. The government has reacted strongly with national actions to address the growing burden posed by diabetes. However our research suggests that the prevalence and mortality of diabetes will continue to rise in the future.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Renders, C. M., Valk, G. D., Griffin, S. J., Wagner, E. H., Eijk van, J. T., & Assendelft, W. J. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1821 · Cited by 1,066
Stevens, G., Dias, R. H., Thomas, K. J. A., Rivera, J. A., Carvalho, N., Barquera, S., Hill, K., & Ezzati, M. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050125 · Cited by 249
Self-citationJiménez-Corona, A., Rojas, R., Gómez-Pérez, F. J., & Aguilar-Salinas, C. A. (2010) · Salud Pública de México · doi:10.1590/s0036-36342010000700006 · Cited by 36 · cited 1×
“However, recent efforts in public institutions are focusing on how to increase insulin use among diabetics [32].”
BackgroundSelf-citation
Cited by
Curran, K., Piyasena, P., Congdon, N., Duke, L., Malanda, B., & Peto, T. (2023) · Health Research Policy and Systems · doi:10.1186/s12961-022-00940-0 · Cited by 21
Metadata
- Authors
- Barquera, S., Campos-Nonato, I., Aguilar-Salinas, C., Lopez-Ridaura, R., Arredondo, A., & Rivera-Dommarco, J.
- Venue
- Globalization and Health
- Published
- 2013-02-02
- Volume
- 9
- Issue
- 1
- Pages
- 3-3
- ISSN
- 1744-8603 (ISSN-L)
- OpenAlex
- W2168210790
- Cited by
- 179
- References
- 3
- FWCI
- 13.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. https://app.cochat.ai/papers/10.1186/1744-8603-9-3
- The paper
- Barquera, S., Campos-Nonato, I., Aguilar-Salinas, C., Lopez-Ridaura, R., Arredondo, A., & Rivera-Dommarco, J. (2013). Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy. Globalization and Health. https://doi.org/10.1186/1744-8603-9-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.